Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10642	Companies
226315	Keywords
154810	Articles
119794	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 12/15/2025 at 15:00, 6 months 10 days ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health announces submission of abstract detailing preliminary findings from clinical trial on a novel oral liquid formulation of crofelemer for SBS-IF patients, supporting the focus on reducing PS needs in intestinal failure patients

Crofelemer Jaguar Health Clinical Trial SBS-IF Intestinal Failure
BRIEF

published on 12/10/2025 at 15:05, 6 months 15 days ago

FDA Extends Conditional Approval for Jaguar Health's Canalevia-CA1

FDA Approval Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy In Dogs
BRIEF

published on 12/10/2025 at 15:05, 6 months 15 days ago

La FDA prolonge l'approbation conditionnelle du Canalevia-CA1 de Jaguar Health

Jaguar Health Canalevia-CA1 Approbation De La FDA Médecine Vétérinaire Chimiothérapie Chez Les Chiens
PRESS RELEASE

published on 12/10/2025 at 15:00, 6 months 15 days ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) receives FDA renewal for Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea (CID) in dogs, with conditional approval extended until December 2026

Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea FDA Renewal
BRIEF

published on 12/08/2025 at 22:20, 6 months 17 days ago

Jaguar Health annonce l'approbation de propositions lors de l'assemblée générale des actionnaires

Crofelemer Jaguar Health Approbation De La FDA Assemblée Générale Des Actionnaires Maladie À Inclusions Microvillositaires
BRIEF

published on 12/08/2025 at 22:20, 6 months 17 days ago

Jaguar Health Announces Approval of Proposals at Stockholder Meeting

Crofelemer Microvillus Inclusion Disease FDA Approval Jaguar Health Stockholder Meeting
PRESS RELEASE

published on 12/08/2025 at 22:15, 6 months 17 days ago

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
Jaguar CEO Lisa Conte to present updates on near-term catalysts at Emerging Growth Conference; Initial results show crofelemer may extend infants' lives with MVID; Jaguar completes FDA meeting on crofelemer trial for MVID treatment

Crofelemer Jaguar Health Lisa Conte Emerging Growth Conference MVID
BRIEF

published on 12/02/2025 at 15:05, 6 months 23 days ago

Jaguar Health sollicite l'approbation de l'EMA pour Canalevia dans le traitement de la diarrhée canine

Jaguar Health Agence Européenne Des Médicaments Diarrhée Du Chien Approbation De Canalevia Traitement Non Antibiotique
BRIEF

published on 12/02/2025 at 15:05, 6 months 23 days ago

Jaguar Health Seeks EMA Approval for Canalevia to Treat Dog Diarrhea

Jaguar Health European Medicines Agency Dog Diarrhea Canalevia Approval Non-antibiotic Treatment
PRESS RELEASE

published on 12/02/2025 at 15:00, 6 months 23 days ago

Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Jaguar Health, Inc. requests advice from EMA on EU approval pathway for Canalevia® in treating general diarrhea in dogs. Novel non-antibiotic approach targets a significant market gap

Jaguar Health Dogs EMA Canalevia General Diarrhea

Accesswire

Published on 06/26/2026 at 01:40, 6 hours 40 minutes ago

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 8 hours 50 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 9 hours 50 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 10 hours 48 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 16 hours 50 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 08:00, 20 minutes ago

MHM Corporate: Debt Restructuring through Bonds Redeemable in Shares
Published on 06/26/2026 at 08:00, 20 minutes ago

MHM Corporate: Restructuration de sa dette par voie d'obligations remboursables en actions
Published on 06/26/2026 at 07:30, 50 minutes ago

REINET INVESTMENTS S.C.A. ANNOUNCES REVISED DATE FOR ANNUAL GENERAL MEETING
Published on 06/26/2026 at 07:30, 50 minutes ago

THE NAGA GROUP AG CONFIRMS FY 2025 REVENUES AND REPORTS STRONGER-THAN-EXPECTED EBITDA
Published on 06/26/2026 at 07:30, 50 minutes ago

Pyrum Innovations AG reports results for the first three months of 2026

Les Echos

Published on 06/26/2026 at 07:00, 1 hour 20 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 1 hour 20 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 13 hours 35 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 13 hours 50 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 14 hours 30 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE